* [[File:Shatavari.jpg|thumb|'''Shatavari (''Asparagus racemosus'')''']]'''Habitat & Distribution:''' Spiny climbing under-shrub native to tropical and subtropical regions of India, Asia, Australia, and parts of Africa.<ref name="Bopana2007">{{cite journal|vauthors=Bopana N, Saxena S|title=Asparagus racemosus—Ethnopharmacological evaluation and conservation needs|journal=Journal of Ethnopharmacology|volume=110|issue=1|pages=1–15|year=2007|doi=10.1016/j.jep.2007.01.001}}</ref><ref name="Alok2013">{{cite journal|vauthors=Alok S, Jain SK, Verma A, Kumar M, Mahor A, Sabharwal M|title=Plant profile, phytochemistry and pharmacology of Asparagus racemosus (Shatavari): A review|journal=Asian Pacific Journal of Tropical Disease|volume=3|issue=3|pages=242–251|year=2013|doi=10.1016/s2222-1808(13)60049-3}}</ref>
* '''Habitat & Distribution:''' Spiny climbing under-shrub native to tropical and subtropical regions of India, Asia, Australia, and parts of Africa.<ref name="Bopana2007">{{cite journal |vauthors=Bopana N, Saxena S |title=Asparagus racemosus—Ethnopharmacological evaluation and conservation needs |journal=Journal of Ethnopharmacology |volume=110 |issue=1 |pages=1–15 |year=2007 |doi=10.1016/j.jep.2007.01.001}}</ref><ref name="Alok2013">{{cite journal |vauthors=Alok S, Jain SK, Verma A, Kumar M, Mahor A, Sabharwal M |title=Plant profile, phytochemistry and pharmacology of Asparagus racemosus (Shatavari): A review |journal=Asian Pacific Journal of Tropical Disease |volume=3 |issue=3 |pages=242–251 |year=2013 |doi=10.1016/s2222-1808(13)60049-3}}</ref>
== Phytochemical profile ==
== Phytochemical profile ==
Line 359:
Line 357:
=== Female reproductive health and endocrine modulation ===
=== Female reproductive health and endocrine modulation ===
The root extract exhibits [[phytoestrogen]]ic properties due to structural similarities between Shatavarins/isoflavones and 17β-[[estradiol]], allowing selective binding to [[estrogen receptor]]s (<math>\text{ER}\alpha</math> and <math>\text{ER}\beta</math>).<ref name="Alok2013" />
The root extract exhibits phytoestrogenic properties due to structural similarities between Shatavarins/isoflavones and 17β-[[estradiol]], allowing selective binding to estrogen receptors (alpha and beta).<ref name="Alok2013" />
* '''Menopausal Symptom Relief:''' Studies demonstrate that ''A. racemosus'' root extracts alleviate vasomotor symptoms (hot flashes, night sweats) and mood fluctuations during pre-, peri-, and post-menopausal phases through partial estrogenic receptor modulation without inducing unwanted endometrial proliferation.<ref name="Alok2013" />
* '''Menopausal Symptom Relief:''' Studies demonstrate that ''A. racemosus'' root extracts alleviate vasomotor symptoms (hot flashes, night sweats) and mood fluctuations during pre-, peri-, and post-menopausal phases through partial estrogenic receptor modulation without inducing unwanted endometrial proliferation.<ref name="Alok2013" />
=== Adaptogenic, neuroprotective and anxiolytic properties ===
=== Adaptogenic, neuroprotective and anxiolytic properties ===
Classified as a ''[[Rasayana]]'' (rejuvenative tonic), Shatavari functions as a systemic [[adaptogen]] by buffering the central nervous system against physical and emotional stressors.<ref name="Bopana2007" /><ref name="Singh2023">{{cite journal |vauthors=Singh N, Garg M, Prajapati P, et al. |title=Adaptogenic property of Asparagus racemosus: Future trends and prospects |journal=Heliyon |volume=9 |issue=4 |pages=e14932 |year=2023 |doi=10.1016/j.heliyon.2023.e14932}}</ref>
Classified as a ''[[Rasayana]]'' (rejuvenative tonic), Shatavari functions as a systemic adaptogen by buffering the central nervous system against physical and emotional stressors.<ref name="Bopana2007" /><ref name="Singh2023">{{cite journal |vauthors=Singh N, Garg M, Prajapati P, et al. |title=Adaptogenic property of Asparagus racemosus: Future trends and prospects |journal=Heliyon |volume=9 |issue=4 |pages=e14932 |year=2023 |doi=10.1016/j.heliyon.2023.e14932}}</ref>
<pre>
<pre>
Line 382:
Line 380:
</pre>
</pre>
* '''Neuroprotection:''' ''In vivo'' models show that root extracts protect hippocampal sub-regions (<math>\text{CA1}</math>, <math>\text{CA3}</math>, and dentate gyrus) from stress-induced cell degeneration by reducing lipid peroxidation and restoring endogenous antioxidant enzymes, such as [[superoxide dismutase]] (<math>\text{SOD}</math>) and [[glutathione]] (<math>\text{GSH}</math>).<ref name="Saxena2007">{{cite journal |vauthors=Saxena G, Singh M, Meena P, et al. |title=Neuroprotective Effects of Asparagus Racemosus Linn Root Extract: An Experimental and Clinical Evidence |journal=Annals of Neurosciences |volume=14 |issue=3 |pages=57–63 |year=2007 |doi=10.5214/ans.0972.7531.2007.140302}}</ref><ref name="Singh2023" />
* '''Neuroprotection:''' ''In vivo'' models show that root extracts protect hippocampal sub-regions (<math>\text{CA1}</math>, <math>\text{CA3}</math>, and dentate gyrus) from stress-induced cell degeneration by reducing lipid peroxidation and restoring endogenous antioxidant enzymes, such as superoxide dismutase (SOD) and glutathione (GSH).<ref name="Saxena2007">{{cite journal |vauthors=Saxena G, Singh M, Meena P, et al. |title=Neuroprotective Effects of Asparagus Racemosus Linn Root Extract: An Experimental and Clinical Evidence |journal=Annals of Neurosciences |volume=14 |issue=3 |pages=57–63 |year=2007 |doi=10.5214/ans.0972.7531.2007.140302}}</ref><ref name="Singh2023" />
* '''Cognitive & Anticonvulsant Support:''' Network pharmacology studies demonstrate that key phytoconstituents target neuro-inflammatory cascade proteins (such as <math>\text{TNF}-\alpha</math>, <math>\text{CASP3}</math>, and <math>\text{PTGS2}</math>), providing protective effects in neurodegenerative and seizure models.<ref name="Kaur2023">{{cite journal |vauthors=Kaur B, Kumar S, Kaur A, Goel RK |title=A network pharmacology approach to explore pharmacological mechanisms of Asparagus racemosus for ameliorative effect in epilepsy and comorbid progressive memory dysfunction |journal=In Silico Pharmacology |volume=11 |issue=1 |pages=28 |year=2023 |doi=10.1007/s40203-023-00169-x}}</ref>
* '''Cognitive & Anticonvulsant Support:''' Network pharmacology studies demonstrate that key phytoconstituents target neuro-inflammatory cascade proteins (such as TNF-alpha, CASP3, and PTGS2), providing protective effects in neurodegenerative and seizure models.<ref name="Kaur2023">{{cite journal |vauthors=Kaur B, Kumar S, Kaur A, Goel RK |title=A network pharmacology approach to explore pharmacological mechanisms of Asparagus racemosus for ameliorative effect in epilepsy and comorbid progressive memory dysfunction |journal=In Silico Pharmacology |volume=11 |issue=1 |pages=28 |year=2023 |doi=10.1007/s40203-023-00169-x}}</ref>
=== Gastroprotective and anti-ulcer activity ===
=== Gastroprotective and anti-ulcer activity ===
Line 389:
Line 387:
* '''Mechanism:''' Rather than purely suppressing gastric acid secretion, it enhances mucosal resistance by increasing mucosal secretion, extending the lifespan of mucosal cells, and reducing gastric hypermotility.
* '''Mechanism:''' Rather than purely suppressing gastric acid secretion, it enhances mucosal resistance by increasing mucosal secretion, extending the lifespan of mucosal cells, and reducing gastric hypermotility.
* '''Therapeutic Application:''' Effective in managing [[duodenal ulcer]]s, hyperacidity, and stress-induced gastric mucosal lesions.<ref name="Bopana2007" /><ref name="Alok2013" />
* '''Therapeutic Application:''' Effective in managing duodenal ulcers, hyperacidity, and stress-induced gastric mucosal lesions.<ref name="Bopana2007" /><ref name="Alok2013" />
Shatavari (Asparagus racemosus)Habitat & Distribution: Spiny climbing under-shrub native to tropical and subtropical regions of India, Asia, Australia, and parts of Africa.[1][2]
Sri Lanka, Nepal, Bangladesh, Bhutan, Myanmar, Thailand, Indonesia, Malaysia
Current researches
Phytochemical profile
The primary therapeutic activity of Asparagus racemosus stems from its rich mixture of steroidal saponins and secondary metabolites concentrated within the tuberous roots.[2]
Phytochemical Profile of Asparagus racemosus
Chemical Class
Key Bioactive Compounds
Biological Significance
Steroidal Saponins
Shatavarins (I–IV), Immunoside, Sarsasapogenin
Phytoestrogenic, galactagogue, and immunomodulatory activity
Nutritional support and metabolic cofactor functions
Pharmacological actions and therapeutic efficacy
Galactagogue effect and lactation enhancement
Asparagus racemosus is recognized in Ayurvedic medicine as a primary galactagogue. Modern clinical trials support its ability to enhance breast milk production by stimulating systemic prolactin release and promoting the growth of mammary lobuloalveolar tissues.[2][8]
Mechanism of Action: Bioactive saponins (specifically Shatavarin I–IV) modulate hormone axes to trigger endogenous prolactin release, leading to alveolar hyperplasia and increased milk synthesis.
Clinical Evidence: Randomized double-blind clinical trials evaluating postpartum women administered A. racemosus root preparations demonstrated a statistically significant increase in maternal serum prolactin levels, enhanced total breast milk output, and proportional infant weight gain compared to placebo groups.[8]
The galactagogue action of Shatavari is attributed to its dual hormonal regulation—boosting prolactin expression while providing systemic antioxidant support to lactating tissue.
Female reproductive health and endocrine modulation
The root extract exhibits phytoestrogenic properties due to structural similarities between Shatavarins/isoflavones and 17β-estradiol, allowing selective binding to estrogen receptors (alpha and beta).[2]
Menopausal Symptom Relief: Studies demonstrate that A. racemosus root extracts alleviate vasomotor symptoms (hot flashes, night sweats) and mood fluctuations during pre-, peri-, and post-menopausal phases through partial estrogenic receptor modulation without inducing unwanted endometrial proliferation.[2]
Adaptogenic, neuroprotective and anxiolytic properties
Classified as a Rasayana (rejuvenative tonic), Shatavari functions as a systemic adaptogen by buffering the central nervous system against physical and emotional stressors.[1][9]
Neuroprotection:In vivo models show that root extracts protect hippocampal sub-regions (<math>\text{CA1}</math>, <math>\text{CA3}</math>, and dentate gyrus) from stress-induced cell degeneration by reducing lipid peroxidation and restoring endogenous antioxidant enzymes, such as superoxide dismutase (SOD) and glutathione (GSH).[10][9]
Cognitive & Anticonvulsant Support: Network pharmacology studies demonstrate that key phytoconstituents target neuro-inflammatory cascade proteins (such as TNF-alpha, CASP3, and PTGS2), providing protective effects in neurodegenerative and seizure models.[11]
Gastroprotective and anti-ulcer activity
A. racemosus root extract acts as a cytoprotective agent within the gastrointestinal tract.[2]
Mechanism: Rather than purely suppressing gastric acid secretion, it enhances mucosal resistance by increasing mucosal secretion, extending the lifespan of mucosal cells, and reducing gastric hypermotility.
Therapeutic Application: Effective in managing duodenal ulcers, hyperacidity, and stress-induced gastric mucosal lesions.[1][2]
Immunomodulatory activity
Shatavari saponins, notably Immunoside and Shatavarin IV, act as biological response modifiers.[2]
Potentiates both humoral and cell-mediated immunity by enhancing macrophage phagocytic activity.
Stimulates leucocytosis and restores immune equilibrium during stress-induced immunosuppression.[1]
Dosage, safety, and toxicology
Standard clinical dosage
Crude Root Powder (Churna): 3–6 g/day in divided doses, traditionally taken with milk or warm water.
Standardized Extract (Water/Ethanol): 500–1000 mg/day (standardized to steroidal saponins).
Toxicology and contraindications
Toxicity: Animal studies demonstrate high safety margins with no significant acute or sub-acute oral toxicity observed at standard therapeutic ranges.[1]
Adverse Effects: Mild, transient gastrointestinal discomfort may occur in sensitive individuals.
Precautions: Patients with estrogen-sensitive conditions (e.g., specific breast or uterine malignancies) should consult a physician prior to high-dose standardized extract therapy due to its phytoestrogenic receptor interaction profile.
Summary and clinical outlook
Asparagus racemosus is an adaptogenic herb with demonstrated clinical applications in female reproductive care, galactagogue support, gastroprotection, and neuroprotection. Modern pharmacological research confirms that its complex array of steroidal saponins, flavonoids, and alkaloids underpins its traditional use as a multi-system restorative agent.
↑ 1.01.11.21.31.41.5Bopana N, Saxena S (2007). "Asparagus racemosus—Ethnopharmacological evaluation and conservation needs". Journal of Ethnopharmacology. 110 (1): 1–15. doi:10.1016/j.jep.2007.01.001.
↑ 2.02.12.22.32.42.52.62.7Alok S, Jain SK, Verma A, Kumar M, Mahor A, Sabharwal M (2013). "Plant profile, phytochemistry and pharmacology of Asparagus racemosus (Shatavari): A review". Asian Pacific Journal of Tropical Disease. 3 (3): 242–251. doi:10.1016/s2222-1808(13)60049-3.
↑Anonymous. The Ayurvedic Pharmacopoeia of India. Department of Ayush, Ministry of Health and Family welfare, Govt. of India, New Delhi, Part I. 1986; Volume IV:50.
↑Anonymous. The Ayurvedic Pharmacopoeia of India. Department of Ayush, Ministry of Health and Family welfare, Govt. of India, New Delhi, Part I. 1986; Volume IV:50.
↑Anonymous. The Ayurvedic Pharmacopoeia of India. Department of Ayush, Ministry of Health and Family welfare, Govt. of India, New Delhi, Part I. 1986; Volume IV:50.
↑ 8.08.1Birla A, Satia M, Shah R, et al. (2022). "Postpartum Use of Shavari Bar® Improves Breast Milk Output: A Double-Blind, Prospective, Randomized, Controlled Clinical Study". Cureus. 14 (8): e26831. doi:10.7759/cureus.26831.
↑ 9.09.1Singh N, Garg M, Prajapati P, et al. (2023). "Adaptogenic property of Asparagus racemosus: Future trends and prospects". Heliyon. 9 (4): e14932. doi:10.1016/j.heliyon.2023.e14932.
↑Saxena G, Singh M, Meena P, et al. (2007). "Neuroprotective Effects of Asparagus Racemosus Linn Root Extract: An Experimental and Clinical Evidence". Annals of Neurosciences. 14 (3): 57–63. doi:10.5214/ans.0972.7531.2007.140302.
↑Kaur B, Kumar S, Kaur A, Goel RK (2023). "A network pharmacology approach to explore pharmacological mechanisms of Asparagus racemosus for ameliorative effect in epilepsy and comorbid progressive memory dysfunction". In Silico Pharmacology. 11 (1): 28. doi:10.1007/s40203-023-00169-x.
